Palvella Therapeutics (NASDAQ:PVLA) said it reported positive top-line results from its phase III SELVA study evaluating QTORIN 3.9% rapamycin in hydrogel as a once-daily topical treatment for ...
Christina Majaski writes and edits finance, credit cards, and travel content. She has 14+ years of experience with print and digital publications. Robert Kelly is managing director of XTS Energy LLC, ...
Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). David Kindness is a Certified Public Accountant (CPA) and an expert in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results